[Form 4] MultiPlan Corporation Insider Trading Activity

Rhea-AI Filing Summary

Claritev Corp (CTEV) reporting person Dalton Travis, who is President, CEO & Executive Chair and a director, reported purchases of Class A common stock totaling 4,282 shares. The Form 4 shows a purchase of 300 shares on 08/08/2025 at a weighted average price of $54.2083 (individual trades ranged $54.18–$54.25) and a purchase of 3,982 shares on 08/11/2025 at a weighted average price of $58.3019 (individual trades ranged $58.06–$58.50). The shares are reported as indirectly beneficially owned in the reporting person’s spouse’s Individual Retirement Account, bringing indirect holdings to 4,282 shares. The Form 4 was executed by attorney-in-fact Kent Bartholomew and dated 08/12/2025.

Positive

• Insider purchases totaling 4,282 Class A shares, indicating acquisition activity by the company’s President/CEO/Executive Chair
• Weighted-average prices and per-trade price ranges disclosed, with footnotes offering to supply detailed trade-level information on request

Negative

• None.

Insights

Financial Analyst

TL;DR: CEO purchases 4,282 Class A shares across two dates, disclosed with weighted-average prices and trade ranges.

The filing records two purchases by Dalton Travis totaling 4,282 Class A shares, with weighted-average prices of $54.2083 and $58.3019 and disclosed per-trade ranges. These are reported as indirect holdings via the reporting person’s spouse's IRA, which affects the reporting of beneficial ownership but still signals acquisition activity by an insider. The disclosure includes footnotes committing to provide transaction-level detail on request. No derivative transactions or 10b5-1 plan checkbox are indicated in the provided text.

Corporate Governance Expert

TL;DR: Insider buying is clearly reported and properly footnoted; ownership is indirect via spouse's IRA and form is signed by attorney-in-fact.

The Form 4 identifies Dalton Travis as both an officer and director and reports indirect acquisitions held in a spouse's Individual Retirement Account, which is material for ownership reporting and potential related-party considerations. The filing includes weighted-average prices and explicit ranges for the multiple transactions, improving transparency. The signature is by an attorney-in-fact, with the filing date shown, meeting standard Form 4 procedural requirements. The transactions do not show any derivative activity or amendments beyond the disclosed purchases.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dalton Travis

(Last) (First) (Middle)

C/O CLARITEV CORPORATION

7900 TYSONS ONE PLACE, SUITE 400

(Street)

MCLEAN VA 22102

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Claritev Corp [ CTEV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Pres., CEO & Executive Chair

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A common stock	08/08/2025		P		300	A	$54.2083(1)	300	I	Spouse's Individual Retirement Account
Class A common stock	08/11/2025		P		3,982	A	$58.3019(2)	4,282	I	Spouse's Individual Retirement Account

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $54.18 to $54.25, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form-4.

2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $58.06 to $58.5, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.

Remarks:

	/s/ Kent Bartholomew, attorney-in-fact	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for Claritev Corp (CTEV)?

Dalton Travis, identified as President, CEO & Executive Chair and a director, filed the Form 4 (signed by attorney-in-fact Kent Bartholomew).

What transactions are reported on the CTEV Form 4?

Two purchases: 300 Class A shares on 08/08/2025 at a weighted average of $54.2083 (trades ranged $54.18–$54.25) and 3,982 Class A shares on 08/11/2025 at a weighted average of $58.3019 (trades ranged $58.06–$58.50).

How many shares does the reporting person beneficially own after these transactions?

4,282 shares are reported as indirectly beneficially owned following the transactions, held in the reporting person’s spouse’s Individual Retirement Account.

Were any derivative securities or 10b5-1 plan transactions reported?

No derivative securities are reported in the provided Table II, and the form does not indicate a checked 10b5-1 plan in the visible content.

When was the Form 4 signed and who signed it?

The Form 4 was signed on 08/12/2025 by attorney-in-fact Kent Bartholomew on behalf of the reporting person.